Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/15/2862741/0/en/Reviva-Reports-Full-Year-2023-Financial-Results-and-Recent-Business-Highlights.html
https://www.globenewswire.com/news-release/2024/03/28/2853940/0/en/Reviva-to-Present-RECOVER-Phase-3-Clinical-Trial-Data-for-Brilaroxazine-in-Schizophrenia-at-the-SIRS-2024-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/03/26/2852291/0/en/Reviva-to-Present-RECOVER-Phase-3-Clinical-Trial-Data-for-Brilaroxazine-in-Schizophrenia-at-the-ASCPT-2024-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/03/11/2843688/0/en/Reviva-to-Present-at-the-UBS-Virtual-CNS-Day.html
https://www.globenewswire.com//news-release/2024/03/07/2842212/0/en/Reviva-to-Present-at-the-36th-Annual-ROTH-Conference.html
https://www.globenewswire.com//news-release/2024/02/20/2831752/0/en/Reviva-Pharmaceuticals-to-Present-at-the-2024-BIO-CEO-Investor-Conference.html
https://www.globenewswire.com//news-release/2024/02/06/2824256/0/en/Reviva-to-Host-KOL-Event-to-Discuss-Topline-Data-from-Phase-3-RECOVER-Trial-of-Brilaroxazine-in-Schizophrenia.html
https://www.globenewswire.com//news-release/2024/01/25/2816679/0/en/Reviva-Pharmaceuticals-to-Participate-in-a-Fireside-Chat-at-the-Lytham-Partners-2024-Investor-Select-Conference.html
https://www.globenewswire.com//news-release/2024/01/04/2803950/0/en/Reviva-Provides-Corporate-and-Program-Updates-and-Highlights-Key-Upcoming-Milestones.html
https://www.globenewswire.com//news-release/2023/12/11/2793793/0/en/Reviva-to-Participate-in-the-Zacks-Small-Cap-Research-Life-Sciences-Investor-Forum.html